Your browser doesn't support javascript.
COVID-19 vaccination and cancer immunotherapy: should they stick together?
Brest, Patrick; Mograbi, Baharia; Hofman, Paul; Milano, Gerard.
  • Brest P; Université Côte d'Azur, CNRS, Inserm, IRCAN, Centre Antoine Lacassagne, FHU-OncoAge, 06189, Nice, France.
  • Mograbi B; Université Côte d'Azur, CNRS, Inserm, IRCAN, Centre Antoine Lacassagne, FHU-OncoAge, 06189, Nice, France.
  • Hofman P; Université Côte d'Azur, CNRS, Inserm, IRCAN, Centre Antoine Lacassagne, FHU-OncoAge, 06189, Nice, France.
  • Milano G; Université Côte d'Azur, Laboratory of Clinical and Experimental Pathology, CHU-Nice, FHU OncoAge, Hospital-Integrated Biobank (BB-0033-00025), Nice, France.
Br J Cancer ; 126(1): 1-3, 2022 01.
Article in English | MEDLINE | ID: covidwho-1526066
ABSTRACT
The combination of COVID-19 vaccination with immunotherapy by checkpoint inhibitors in cancer patients could intensify immunological stimulation with potential reciprocal benefits. Here, we examine more closely the possible adverse events that can arise in each treatment modality. Our conclusion is that caution should be exercised when combining both treatments.
Subject(s)
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Immune Checkpoint Inhibitors / COVID-19 / BNT162 Vaccine / Immunotherapy / Neoplasms Topics: Vaccines Limits: Humans Language: English Journal: Br J Cancer Year: 2022 Document Type: Article Affiliation country: S41416-021-01618-0

Similar

MEDLINE
LILACS
LIS
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Immune Checkpoint Inhibitors / COVID-19 / BNT162 Vaccine / Immunotherapy / Neoplasms Topics: Vaccines Limits: Humans Language: English Journal: Br J Cancer Year: 2022 Document Type: Article Affiliation country: S41416-021-01618-0